Reported about 14 hours ago
Bionano Genomics, Inc. (NASDAQ:BNGO) has announced a public offering of 5 million shares at $2.00 each, aiming to raise $10 million in gross proceeds, with the potential to secure an additional $20 million if warrants are exercised. The funds will support the company's expansion into clinical and anatomic pathology, leveraging its optical genome mapping (OGM) technology to enhance utilization among routine users and improve profitability.
Source: YAHOO